逍遥合剂治疗肠易激综合征肝郁脾虚证的临床观察

Clinical Observation of XiaoYao Mistura in the Treatment of Stagnation of Liver-qi and Spleen Deficiency of Irritable Bowel Syndrome

为评价逍遥合剂对肠易激综合征肝郁脾虚证的治疗效果和安全性，将180例肠易激综合征患者分为治疗组和对照组。治疗组120例服逍遥合剂，对照组60例服得舒特，观察症状改善及疗效情况。治疗组和对照组总有效率分别为97.2％和96．1％（P〉0．05）。结果表明，逍遥合剂治疗肠易激综合征肝郁脾虚证的临床疗效与得舒特作用相近。

For evaluating the therapeutic effects and safety of XiaoYao Mistura for stagnation of liver-qi and spleen deficiency of irritable bowel syndrome,authors divided the 180 patients into treatment group and controlled group. Treatment group（ n = 120） was administrated this mistura and controlled group（ n=60） was taken deshute（i, e pinaverium bromide）. Then their states of symptoms improvement and therapeutic effects were observed. Total effective rates of treatment group and controlled group were 97.2% and 96. 1% （ P 〈0.05） respectively. It is indicated that XiaoYao Mistura in the therapeutic effects for stagnation of liver-qi and spleen deficiency of irritable bowel syndrome is closed to deshute.